"Cardiomegaly" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Descriptor ID |
D006332
|
| MeSH Number(s) |
C14.280.195 C23.300.775.250
|
| Concept/Terms |
Cardiomegaly- Cardiomegaly
- Heart Enlargement
- Enlargement, Heart
- Enlarged Heart
- Heart, Enlarged
|
Below are MeSH descriptors whose meaning is more general than "Cardiomegaly".
Below are MeSH descriptors whose meaning is more specific than "Cardiomegaly".
This graph shows the total number of publications written about "Cardiomegaly" by people in this website by year, and whether "Cardiomegaly" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 8 | 6 | 14 |
| 1996 | 3 | 5 | 8 |
| 1997 | 4 | 3 | 7 |
| 1998 | 7 | 4 | 11 |
| 1999 | 5 | 4 | 9 |
| 2000 | 3 | 1 | 4 |
| 2001 | 9 | 3 | 12 |
| 2002 | 5 | 2 | 7 |
| 2003 | 6 | 6 | 12 |
| 2004 | 7 | 7 | 14 |
| 2005 | 9 | 10 | 19 |
| 2006 | 11 | 1 | 12 |
| 2007 | 13 | 3 | 16 |
| 2008 | 16 | 1 | 17 |
| 2009 | 10 | 13 | 23 |
| 2010 | 13 | 8 | 21 |
| 2011 | 12 | 7 | 19 |
| 2012 | 15 | 5 | 20 |
| 2013 | 14 | 3 | 17 |
| 2014 | 12 | 9 | 21 |
| 2015 | 16 | 7 | 23 |
| 2016 | 13 | 7 | 20 |
| 2017 | 12 | 2 | 14 |
| 2018 | 7 | 7 | 14 |
| 2019 | 5 | 3 | 8 |
| 2020 | 7 | 2 | 9 |
| 2021 | 10 | 3 | 13 |
| 2022 | 1 | 4 | 5 |
| 2023 | 1 | 6 | 7 |
| 2024 | 3 | 5 | 8 |
Below are the most recent publications written about "Cardiomegaly" by people in Profiles.
-
Loss of cardiomyocyte-specific adhesion G-protein-coupled receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure. Biosci Rep. 2024 09 25; 44(9).
-
Therapeutic Inhibition of LincRNA-p21 Protects Against Cardiac Hypertrophy. Circ Res. 2024 Jul 19; 135(3):434-449.
-
IRE1α Mediates the Hypertrophic Growth of Cardiomyocytes Through Facilitating the Formation of Initiation Complex to Promote the Translation of TOP-Motif Transcripts. Circulation. 2024 Sep 24; 150(13):1010-1029.
-
Circadian control of histone turnover during cardiac development and growth. J Biol Chem. 2024 Jul; 300(7):107434.
-
The long noncoding RNA CARDINAL attenuates cardiac hypertrophy by modulating protein translation. J Clin Invest. 2024 May 14; 134(13).
-
Using generative AI to investigate medical imagery models and datasets. EBioMedicine. 2024 Apr; 102:105075.
-
Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy. Circ Res. 2024 Mar 29; 134(7):913-930.
-
ATF6 protects against protein misfolding during cardiac hypertrophy. J Mol Cell Cardiol. 2024 Apr; 189:12-24.
-
Effect of Maternal Preeclampsia on Cardiac Structure and Function in Very Low Birth Weight Infants. Am J Perinatol. 2024 05; 41(S 01):e3413-e3419.
-
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation. 2024 01 16; 149(3):227-250.